FealtySign in

DOLLAR TREE, INC.

(DLTR)

CIK 935703 · SEC filings only

Not yet gradedBuyback record
harness minimum not met
company entity
2 resolved promises

Not enough resolved promises to grade

2 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Credibility timeline

PARTIAL · Mar 16, 2021PARTIAL · May 25, 2023
20212023
Timeline as a list
  • Mar 16, 2021PARTIALThe Company has an existing $1.0 billion board authorization to repurchase shares
  • May 25, 2023PARTIALthe Company now has a $2.4 billion share repurchase authorization
2 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
AGuidance record
grade
company entity
25 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (66)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance q · May 28, 2026
    Adjusted diluted EPS for the second quarter 2026 is estimated to be in the range of $1.00 to $1.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · May 28, 2026
    Adjusted diluted earnings per share in the range of $6.70 to $7.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Mar 16, 2026
    Adjusted diluted earnings per share in the range of $6.50 to $6.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance q · Mar 16, 2026
    Adjusted diluted EPS for the first quarter 2026 is estimated to be in the range of $1.45 to $1.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance q · Dec 3, 2025
    it expects adjusted diluted EPS from continuing operations to be in the range of $2.40 to $2.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Dec 3, 2025
    The Company is updating its prior adjusted diluted EPS from continuing operations outlook range to $5.60 to $5.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Sep 3, 2025
    The company is updating its prior adjusted diluted EPS from continuing operations outlook range to $5.32 to $5.72
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Jun 4, 2025
    The Company is updating its prior adjusted diluted EPS from continuing operations outlook range to $5.15 to $5.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance q · Jun 4, 2025
    we expect second quarter adjusted EPS from continuing operations could be down as much as 45 to 50 percent year-over-year
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance q · Mar 26, 2025
    Adjusted diluted EPS for the first quarter 2025 is estimated to be in the range of $1.10 to $1.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · Mar 26, 2025
    Adjusted diluted EPS from continuing operations is expected to range from $5.00 to $5.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance q · Dec 4, 2024
    Adjusted diluted EPS for the fourth quarter 2024 is estimated to be in the range of $2.10 to $2.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Dec 4, 2024
    Adjusted diluted EPS is expected to range from $5.31 to $5.51
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Sep 4, 2024
    Adjusted diluted EPS is expected to range from $5.20 to $5.60.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance q · Sep 4, 2024
    Adjusted diluted EPS for the third quarter 2024 is estimated to be in the range of $1.05 to $1.15.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance q · Jun 5, 2024
    Adjusted diluted EPS for the quarter is estimated to be in the range of $1.00 to $1.10.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance fy · Jun 5, 2024
    Adjusted diluted EPS is expected to range from $6.50 to $7.00.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance q · Mar 13, 2024
    Diluted EPS for the quarter is estimated to be in the range of $1.33 to $1.48
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Mar 13, 2024
    Diluted EPS is expected to range from $6.70 to $7.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Nov 29, 2023
    Diluted EPS is expected to range from $5.81 to $6.01
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance q · Nov 29, 2023
    Diluted EPS for the quarter is estimated to be in the range of $2.58 to $2.78
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Aug 24, 2023
    Diluted EPS is expected to range from $5.78 to $6.08
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance q · Aug 24, 2023
    Diluted EPS for the quarter is estimated to be in the range of $0.94 to $1.04.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance q · May 25, 2023
    Diluted EPS for the quarter is estimated to be in the range of $0.79 to $0.89
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance fy · May 25, 2023
    Diluted EPS is expected to range from $5.73 to $6.13
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance q · Mar 1, 2023
    Diluted EPS for the quarter is estimated to be in the range of $1.46 to $1.56.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · Mar 1, 2023
    Diluted EPS is expected to range from $6.30 to $6.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Nov 22, 2022
    Diluted earnings per share for fiscal 2022 are expected to be in the lower half of the Company’s previously provided outlook range of $7.10 to $7.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · Aug 25, 2022
    Diluted earnings per share for full-year fiscal 2022 are now expected to range from $7.10 to $7.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance q · Aug 25, 2022
    Diluted earnings per share for the quarter are estimated to be in the range of $1.05 to $1.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance fy · May 26, 2022
    Diluted earnings per share for full-year fiscal 2022 are now expected to range from $7.80 to $8.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance q · May 26, 2022
    Diluted earnings per share for the quarter are estimated to be in the range of $1.45 to $1.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance q · Mar 2, 2022
    Diluted earnings per share for the quarter are estimated to be in the range of $1.95 to $2.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. eps guidance fy · Mar 2, 2022
    Diluted earnings per share are expected to range from $7.60 to $8.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance fy · Nov 23, 2021
    The Company now estimates diluted earnings per share will range from $5.48 to $5.58
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance q · Nov 23, 2021
    Diluted earnings per share are estimated to be in the range of $1.69 to $1.79
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance fy · Aug 26, 2021
    The Company now estimates diluted earnings per share will range from $5.40 to $5.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance q · Aug 26, 2021
    Diluted earnings per share are estimated to be in the range of $0.88 to $0.98
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance fy · May 27, 2021
    For full-year fiscal 2021, the Company estimates diluted earnings per share will range between $5.80 and $6.05.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Aug 29, 2019
    The Company now anticipates net income per diluted share for full-year fiscal 2019 will range between $4.90 and $5.11
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. eps guidance q · Aug 29, 2019
    Diluted earnings per share are estimated to be in the range of $1.07 to $1.16
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  42. eps guidance fy · Nov 29, 2018
    The Company now anticipates net income per diluted share for full-year fiscal 2018 will range between $4.86 and $4.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance q · Nov 29, 2018
    Diluted earnings per share are estimated to be in the range of $1.86 to $1.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  44. eps guidance q · May 31, 2018
    Diluted earnings per share are estimated to be in the range of $1.07 to $1.16
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  45. eps guidance fy · May 31, 2018
    The Company now anticipates net income per diluted share for full-year fiscal 2018 will range between $4.80 and $5.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  46. eps guidance q · Aug 24, 2017
    Diluted earnings per share are estimated to be in the range of $0.83 to $0.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  47. eps guidance fy · Aug 24, 2017
    The Company now anticipates net income per diluted share for full-year fiscal 2017 will range between $4.44 and $4.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  48. eps guidance q · May 25, 2017
    Diluted earnings per share are estimated to be in the range of $0.80 to $0.88
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  49. eps guidance fy · May 25, 2017
    the Company now anticipates net income per diluted share for full-year fiscal 2017 will range between $4.17 and $4.43
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  50. eps guidance fy · Mar 1, 2017
    Fiscal 2017 diluted earnings per share are expected to range from $4.20 to $4.56
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  51. eps guidance q · Mar 1, 2017
    Diluted earnings per share are estimated to be in the range of $0.91 to $0.98
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  52. eps guidance fy · Aug 25, 2016
    The Company now anticipates net income per diluted share for full-year 2016 will range between $3.67 and $3.82
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  53. eps guidance q · Aug 25, 2016
    Diluted earnings per share are estimated to be in the range of $0.76 to $0.82
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  54. eps guidance q · Nov 24, 2015
    Net income and adjusted cash EPS per diluted share for the fourth quarter are estimated to be in the ranges of $213.2 million to $242.2 million and $2.32 to $2.51, respectively.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  55. eps guidance q · Feb 25, 2015
    Diluted earnings per share, excluding acquisition-related costs, are expected to range from $0.69 to $0.74
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  56. eps guidance fy · Feb 25, 2015
    Fiscal year 2015 diluted earnings per share, excluding acquisition-related costs, are expected to range from $3.30 to $3.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  57. eps guidance fy · May 22, 2014
    Fiscal year 2014 diluted earnings per share are expected to be $2.94 to $3.12
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  58. eps guidance q · May 22, 2014
    Diluted earnings per share are estimated to be in the range of $0.58 to $0.64
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  59. eps guidance fy · Aug 22, 2013
    Diluted earnings per share are expected to be $2.65 to $2.77
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  60. eps guidance q · Aug 22, 2013
    Diluted earnings per share are estimated to be in the range of $0.54 to $0.59
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  61. eps guidance fy · Feb 27, 2013
    Fiscal year 2013 diluted earnings per share are expected to be in the range of $2.54 to $2.74
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  62. eps guidance q · Feb 27, 2013
    Diluted earnings per share are expected to be in the range of $0.53 to $0.58
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  63. eps guidance q · Aug 16, 2012
    Diluted earnings per share are estimated to be in the range of $0.47 to $0.51
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  64. eps guidance fy · Aug 16, 2012
    Diluted earnings per share are expected to be $2.45 to $2.54
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  65. eps guidance q · Feb 22, 2012
    Diluted earnings per share are expected to be in the range of $0.91 to $0.97
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  66. eps guidance fy · Feb 22, 2012
    Fiscal year 2012 diluted earnings per share are expected to be in the range of $4.65 to $4.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (21) · 20 superseded

Open · revenue guidance q

The Company estimates sales for the first quarter of 2012 to be in the range of $1.65 billion to $1.69 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates sales for the third quarter of 2012 to be in the range of $1.71 billion to $1.75 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Full year sales are now estimated to be in the range of $7.36 billion to $7.45 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates sales for the first quarter of 2013 to be in the range of $1.84 billion to $1.89 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates sales for the third quarter of 2013 to be in the range of $1.87 billion to $1.92 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Full year sales are now estimated to be in the range of $7.85 billion to $7.97 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates sales for the second quarter of 2014 to be in the range of $1.97 billion to $2.02 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Full year sales are now estimated to be in the range of $8.37 billion to $8.54 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the first quarter of 2015 to range from $2.15 billion to $2.20 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

For the full year, the Company estimates consolidated net sales to range from $15.45 billion to $15.55 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the fourth quarter of 2015 to range from $5.32 billion to $5.42 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the third quarter of 2016 to range from $5.02 billion to $5.10 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Consolidated net sales for full-year 2016 are now expected to range between $20.69 billion and $20.87 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the first quarter of 2017 to range from $5.26 billion to $5.35 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the second quarter of 2017 to range from $5.18 billion to $5.28 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the third quarter of 2017 to range from $5.20 billion to $5.29 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance fy

Consolidated net sales for full-year fiscal 2017 are now expected to range from $22.07 billion to $22.28 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company estimates consolidated net sales for the second quarter of 2018 to range from $5.47 billion to $5.57 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

The Company expects consolidated net sales for the fourth quarter will range from $8.1 billion to $8.3 billion

unresolved — no outcome on filereceipt →
Open · revenue guidance q

net sales from continuing operations for the second quarter will range from $4.8 billion to $4.9 billion

resolves in ~20 daysreceipt →
Open · revenue guidance fy

Net sales from continuing operations in the range of $20.5 billion to $20.7 billion

resolves in ~202 daysreceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2023 are now expected to range from $30.6 billion to $30.9 billion.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for the year are now expected to range from $27.76 billion to $28.14 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for the full year are estimated to range from $9.21 billion to $9.45 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

The Company continues to expect its full-year fiscal 2025 net sales from continuing operations to be in the range of $18.5 billion to $19.1 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for the year are now expected to range from $27.85 billion to $28.10 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2021 are expected to range from $26.19 billion to $26.44 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Net sales from continuing operations in the range of $20.5 to $20.7 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For fiscal 2017, the Company estimates consolidated net sales will range from $21.94 billion to $22.33 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2022 are expected to range from $27.22 billion to $27.85 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2023 are now expected to range from $30.0 billion to $30.5 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2023 are expected to range from $29.9 billion to $30.5 billion.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For the full year, the Company estimates sales will range from $7.79 billion to $7.97 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2017 are now expected to range from $21.95 billion to $22.25 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

The Company is reiterating its full-year fiscal 2024 consolidated net sales outlook range of $31.0 billion to $32.0 billion.

revised by a later guidancereceipt →
Superseded · revenue guidance fy

The Company now expects its full-year fiscal 2025 net sales from continuing operations to be in the range of $19.3 billion to $19.5 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2024 are expected to range from $31.0 billion to $32.0 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

The Company expects its full-year fiscal 2025 net sales from continuing operations to be in the range of $18.5 billion to $19.1 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

For the full year, the Company estimates sales will range from $7.25 billion to $7.42 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Consolidated net sales for full-year fiscal 2018 are now expected to range from $22.73 billion to $23.05 billion

revised by a later guidancereceipt →
Superseded · revenue guidance fy

The Company is adjusting its full-year fiscal 2024 consolidated net sales outlook range to $30.6 billion to $30.9 billion.

revised by a later guidancereceipt →

Credibility timeline

BEAT · Aug 24, 2023KEPT · Nov 29, 2023KEPT · Mar 20, 2024KEPT · Mar 20, 2024KEPT · Jun 5, 2024KEPT · Sep 4, 2024KEPT · Dec 4, 2024MISSED · Mar 26, 2025BEAT · Jun 4, 2025KEPT · Mar 16, 2026KEPT · Mar 16, 2026KEPT · May 28, 2026
20232026
Timeline as a list
  • Aug 24, 2023BEATThe Company expects consolidated net sales for the second quarter will range from $7.0 billion to $7.2 billion
  • Nov 29, 2023KEPTThe Company expects consolidated net sales for the third quarter will range from $7.3 billion to $7.5 billion
  • Mar 20, 2024KEPTThe Company expects consolidated net sales for the fourth quarter will range from $8.6 billion to $8.8 billion
  • Mar 20, 2024KEPTConsolidated net sales for full-year fiscal 2023 are now expected to range from $30.5 billion to $30.7 billion.
  • Jun 5, 2024KEPTThe Company expects consolidated net sales for the first quarter will range from $7.6 billion to $7.9 billion
  • Sep 4, 2024KEPTThe Company expects consolidated net sales for the second quarter will range from $7.3 billion to $7.6 billion
  • Dec 4, 2024KEPTThe Company expects consolidated net sales for the third quarter will range from $7.4 billion to $7.6 billion
  • Mar 26, 2025MISSEDThe Company is updating its full-year fiscal 2024 consolidated net sales outlook range to $30.7 billion to $30.9 billion
  • Jun 4, 2025BEATThe Company expects net sales from continuing operations for the first quarter will range from $4.5 billion to $4.6 billion
  • Mar 16, 2026KEPTThe Company is updating its full-year fiscal 2025 net sales from continuing operations outlook to be in the range of $19.35 billion to $19.45 billion
  • Mar 16, 2026KEPTthe Company expects its net sales from continuing operations to be in the range of $5.4 billion to $5.5 billion
  • May 28, 2026KEPTnet sales from continuing operations for the first quarter will range from $4.9 billion to $5.0 billion
25 resolved guidance promises · 66dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →